You are here

  • Home
  • Archive
  • Volume 67, Issue 11
  • The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

Article info

Article menu

Download PDFPDF

Guidelines
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
Free

Authors

  • Benjamin H Mullish Division of Integrative Systems Medicine and Digestive Disease, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK Departments of Gastroenterology and Hepatology, St Mary’s Hospital, Imperial College Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  • Mohammed Nabil Quraishi Department of Gastroenterology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK PubMed articlesGoogle scholar articles
  • Jonathan P Segal Division of Integrative Systems Medicine and Digestive Disease, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK Inflammatory Bowel Disease Unit, St Mark’s Hospital, London, UK PubMed articlesGoogle scholar articles
  • Victoria L McCune Public Health England, Public Health Laboratory Birmingham, Birmingham, UK Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK PubMed articlesGoogle scholar articles
  • Melissa Baxter Department of Microbiology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK PubMed articlesGoogle scholar articles
  • Gemma L Marsden Healthcare Infection Society, London, UK PubMed articlesGoogle scholar articles
  • David J Moore Institute of Applied Health Research, University of Birmingham, Birmingham, UK PubMed articlesGoogle scholar articles
  • Alaric Colville Department of Microbiology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK PubMed articlesGoogle scholar articles
  • Neeraj Bhala Department of Gastroenterology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK Institute of Applied Health Research, University of Birmingham, Birmingham, UK Institute of Translational Medicine, University of Birmingham, Birmingham, UK PubMed articlesGoogle scholar articles
  • Tariq H Iqbal Department of Gastroenterology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK Institute of Translational Medicine, University of Birmingham, Birmingham, UK PubMed articlesGoogle scholar articles
  • Christopher Settle Department of Microbiology, City Hospitals Sunderland NHS Foundation Trust, Sunderland, Sunderland, UK PubMed articlesGoogle scholar articles
  • Graziella Kontkowski C diff Support, London, UK PubMed articlesGoogle scholar articles
  • Ailsa L Hart Division of Integrative Systems Medicine and Digestive Disease, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK Inflammatory Bowel Disease Unit, St Mark’s Hospital, London, UK PubMed articlesGoogle scholar articles
  • Peter M Hawkey Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK PubMed articlesGoogle scholar articles
  • Simon D Goldenberg Centre for Clinical Infection and Diagnostics Research, King’s College London, London, UK Department of Microbiology, Guy’s and St Thomas' NHS Foundation Trust, London, UK PubMed articlesGoogle scholar articles
  • Horace R T Williams Division of Integrative Systems Medicine and Digestive Disease, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK Departments of Gastroenterology and Hepatology, St Mary’s Hospital, Imperial College Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Horace R T Williams, Department of Gastroenterology, St Mary’s Hospital, Imperial College Healthcare NHS Trust, London, W2 1NY, UK; h.williams{at}imperial.ac.uk
View Full Text

Citation

Mullish BH, Quraishi MN, Segal JP, et al
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
Gut 2018;67:1920-1941.

Publication history

  • Received May 16, 2018
  • Revised June 27, 2018
  • Accepted July 1, 2018
  • First published August 28, 2018.
Online issue publication 
June 29, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.